{"url":"https://lda.gov/api/v1/filings/180006ef-c60d-44c9-918a-ea75812aa42a/","filing_uuid":"180006ef-c60d-44c9-918a-ea75812aa42a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/180006ef-c60d-44c9-918a-ea75812aa42a/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Skelton","dt_posted":"2026-04-20T16:39:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"c/o 28 Liberty Ship Way, Suite 2815","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Sausalito","registrant_state":"CA","registrant_zip":"94965","registrant":{"id":401103510,"url":"https://lda.gov/api/v1/registrants/401103510/","house_registrant_id":null,"name":"SAREPTA THERAPEUTICS, INC.","description":"Biopharmaceutical company","address_1":"c/o 28 Liberty Ship Way, Suite 2815","address_2":null,"address_3":null,"address_4":null,"city":"Sausalito","state":"CA","state_display":"California","zip":"94965","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE UNGER SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-07-23T16:08:48.090815-04:00"},"client":{"id":199232,"url":"https://lda.gov/api/v1/clients/199232/","client_id":12,"name":"SAREPTA THERAPEUTICS, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-12-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Duchenne Muscular Dystrophy and Rare Disease Patient Access to Treatments Newborn Screening for Rare Diseases","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153690,"prefix":null,"prefix_display":null,"first_name":"MADISON","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Scientific Innovation in Healthcare Gene Therapies Artificial Intelligence and Data Governance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153690,"prefix":null,"prefix_display":null,"first_name":"MADISON","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}